Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2013; 19(46): 8714-8721
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8714
Figure 1
Figure 1 Immunodetected differential LGR5 expression in gastric tissues, following progression of tumorigenesis, and in distant metastases. Representative samples are shown from leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5)- (A) and LGR5+ (B) normal gastric normal tissues, LGR5- (C) and LGR5+ (D-F) gastric cancer (GC) tissues with weak, moderate and strong expression, LGR5+ gastric intestinal metaplasia and dysplasia tissues (G, H), and LGR5+ lymph node and liver metastases (I, J). A, C-J: Magnification: × 200; B: Magnification: × 100.